1. Home
  2. ALVOW vs REGCP Comparison

ALVOW vs REGCP Comparison

Compare ALVOW & REGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVOW
  • REGCP
  • Stock Information
  • Founded
  • ALVOW 2013
  • REGCP N/A
  • Country
  • ALVOW Luxembourg
  • REGCP United States
  • Employees
  • ALVOW 999
  • REGCP 497
  • Industry
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • REGCP
  • Sector
  • ALVOW Health Care
  • REGCP
  • Exchange
  • ALVOW Nasdaq
  • REGCP Nasdaq
  • Market Cap
  • ALVOW N/A
  • REGCP N/A
  • IPO Year
  • ALVOW N/A
  • REGCP N/A
  • Fundamental
  • Price
  • ALVOW $1.83
  • REGCP $23.57
  • Analyst Decision
  • ALVOW
  • REGCP
  • Analyst Count
  • ALVOW 0
  • REGCP 0
  • Target Price
  • ALVOW N/A
  • REGCP N/A
  • AVG Volume (30 Days)
  • ALVOW 15.0K
  • REGCP N/A
  • Earning Date
  • ALVOW 02-27-2025
  • REGCP N/A
  • Dividend Yield
  • ALVOW N/A
  • REGCP N/A
  • EPS Growth
  • ALVOW N/A
  • REGCP N/A
  • EPS
  • ALVOW N/A
  • REGCP N/A
  • Revenue
  • ALVOW $393,919,000.00
  • REGCP N/A
  • Revenue This Year
  • ALVOW N/A
  • REGCP N/A
  • Revenue Next Year
  • ALVOW N/A
  • REGCP N/A
  • P/E Ratio
  • ALVOW N/A
  • REGCP N/A
  • Revenue Growth
  • ALVOW 517.92
  • REGCP N/A
  • 52 Week Low
  • ALVOW $2.33
  • REGCP N/A
  • 52 Week High
  • ALVOW $2.33
  • REGCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • ALVOW N/A
  • REGCP 52.95
  • Support Level
  • ALVOW N/A
  • REGCP $23.50
  • Resistance Level
  • ALVOW N/A
  • REGCP $23.71
  • Average True Range (ATR)
  • ALVOW 0.00
  • REGCP 0.18
  • MACD
  • ALVOW 0.00
  • REGCP 0.04
  • Stochastic Oscillator
  • ALVOW 0.00
  • REGCP 77.78

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

About REGCP Regency Centers Corporation

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

Share on Social Networks: